|
1) Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991; 352: 337-9
|
|
|
|
2) Superti-Furga A, Gugler E, Gitzelmann R, et al. Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen. J Biol Chem. 1988; 263: 6226-32
|
|
|
|
|
|
3) Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neuro-cognitive and skeletal development caused by mu-tations in TGFBR1 or TGFBR2. Nat Genet. 2005; 37: 275-81
|
|
|
|
|
4) Coucke PJ, Willaert A, Wessels MW, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006; 38: 452-7
|
|
|
|
|
|
5) van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet. 2011; 43: 121-6
|
|
|
|
|
|
6) Guo DC, Pannu H, Tran-Fadulu V, et al. Mu-tations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007; 39: 1488-93
|
|
|
|
|
|
7) Zhu L, Vranckx R, Van Kien PK, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006; 38: 343-9
|
|
|
|
|
|
8) Wang L, Guo DC, Cao J, et al. Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet. 2010; 87: 701-7
|
|
|
|
|
|
9) Albornoz G, Coady MA, Roberts M, et al. Familial thoracic aortic aneurysms and dissec-tions--incidence, modes of inheritance, and pheno-typic patterns. Ann Thorac Surg. 2006; 82: 1400-5
|
|
|
|
|
|
10) De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996; 62: 417-26
|
|
|
|
|
|
11) Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010; 47: 476-85
|
|
|
|
|
|
12) Faivre L, Collod-Beroud G, Loeys BL, et al. Effect of mutation type and location on clinical out-come in 1, 013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet. 2007; 81: 454-66
|
|
|
|
|
|
13) Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006; 312: 117-21
|
|
|
|
|
|
14) Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006; 355: 788-98
|
|
|
|
|
|
15) Mizuguchi T, Collod-Beroud G, Akiyama T, et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet. 2004; 36: 855-60
|
|
|
|
|
|
16) Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998; 77: 31-7
|
|
|
|
|
|
17) Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007; 2: 32
|
|
|
|
|
|
18) Vaughan CJ, Casey M, He J, et al. Identification of a chromosome 11q23. 2-q24 locus for familial aortic aneurysm disease, a genetically hetero-geneous disorder. Circulation. 2001; 103: 2469-75
|
|
|
|
|
|
19) Guo D, Hasham S, Kuang SQ, et al. Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation. 2001; 103: 2461-8
|
|
|
|
|
|
20) Hasham SN, Willing MC, Guo DC, et al. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation. 2003; 107: 3184-90
|
|
|
|
|
|
21) Khau Van Kien P, Mathieu F, Zhu L, et al. Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12. 2-p13. 13. Circulation. 2005; 112: 200-6
|
|
|
|
|
|
22) Morisaki H, Akutsu K, Ogino H, et al. Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD). Hum Mutat. 2009; 7: 7
|
|
|
|
|
|
23) Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009; 84: 617-27
|
|
|
|
|
|
24) Milewicz DM, Ostergaard JR, Ala-Kokko LM, et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet. 2010; 152A: 2437-43
|
|
|
|
|
|
25) Dietz HC, Loeys B, Carta L, et al. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005; 139: 4-9
|
|
|
|
|